R

Rallybio Corp
D

RLYB

1.08000
USD
-0.01
(-0.92%)
Market Closed
Volume
30
EPS
-1
Div Yield
-
P/E
-1
Market Cap
44,806,593
OverviewSignalsIdeasNews
Related Instruments
    BKNG
    BKNG
    -4.00
    (-0.08%)
    5,210.84 USD
    C
    CCL
    -0.015
    (-0.06%)
    24.295 USD
    E
    EXPE
    -0.840
    (-0.46%)
    181.420 USD
    HLT
    HLT
    -1.740
    (-0.70%)
    248.400 USD
    MAR
    MAR
    -3.25
    (-1.15%)
    278.73 USD
    N
    NCLH
    -0.260
    (-0.97%)
    26.410 USD
    RCL
    RCL
    -1.590
    (-0.68%)
    231.510 USD
    T
    TRIP
    -0.645
    (-4.43%)
    13.930 USD
    W
    WYNN
    -2.530
    (-2.71%)
    90.730 USD
    More
News

Title: Rallybio Corp

Sector: Healthcare
Industry: Biotechnology
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.